| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $10.69 ▼ -0.80% | Yesterday | $10.82 ▲ +0.33% | Tomorrow's ADMA Biologics Inc Common Stock (ADMA) setup is anchored to $10.78 and targets $10.69 (-0.80%). The near-term read is downside; watch $11.10 / $10.46 because daily realized volatility is about 4.10%. |
Tomorrow's ADMA Biologics Inc Common Stock (ADMA) setup is anchored to $10.78 and targets $10.69 (-0.80%). The near-term read is downside; watch $11.10 / $10.46 because daily realized volatility is about 4.10%. | ||||
| Week | $10.51 ▼ -2.48% | Last Week | $10.89 ▲ +1.04% | The 7-day ADMA Biologics Inc Common Stock model moves from $10.89 to $10.51 (-2.48%). It gives downside momentum context for this stock, so breaks around $11.10 / $10.46 matter more than a single tick. |
The 7-day ADMA Biologics Inc Common Stock model moves from $10.89 to $10.51 (-2.48%). It gives downside momentum context for this stock, so breaks around $11.10 / $10.46 matter more than a single tick. | ||||
| Month | $10.21 ▼ -5.27% | Last Month | $11.02 ▲ +2.21% | The 1-month ADMA Biologics Inc Common Stock target is $10.21 (-5.27%), compared with the live reference near $10.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month ADMA Biologics Inc Common Stock target is $10.21 (-5.27%), compared with the live reference near $10.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $9.76 ▼ -9.46% | Last Year | $11.21 ▲ +3.97% | The 1-year ADMA Biologics Inc Common Stock scenario points to $9.76 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year ADMA Biologics Inc Common Stock scenario points to $9.76 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $8.70 ▼ -19.29% | 5 Years Ago | $11.65 ▲ +8.10% | The 5-year ADMA Biologics Inc Common Stock view is $8.70 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year ADMA Biologics Inc Common Stock view is $8.70 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $10.78 | Mid |
| Daily Change | -0.92% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 59% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $10.78 | Daily Change | -0.92% |
| Market Cap | $2.57B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.